Chronic Myeloproliferative Disorders
129
3
4
90
Key Insights
Highlights
Success Rate
78% trial completion
Published Results
27 trials with published results (21%)
Research Maturity
90 completed trials (70% of total)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 77/100
20.2%
26 terminated out of 129 trials
77.6%
-8.9% vs benchmark
11%
14 trials in Phase 3/4
30%
27 of 90 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 90 completed trials
Clinical Trials (129)
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer
Registry of Older Patients With Cancer
Donor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other Disorders
Donor Stem Cell Transplant, Pentostatin, and Total-Body Irradiation in Treating Patients With Hematological Cancer
Shorter Course Tacro After NMA, Related Donor PBSCT With High-dose Posttransplant Cy for Hard-to-Engraft Malignancies
Sargramostim in Reducing Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplantation for Hematologic Cancer or Aplastic Anemia
Research Study in Healthy Volunteers of Patients With Fanconi Anemia, Myeloproliferative Disorders, or Myeloma
Collecting and Storing Blood Samples From Patients With Cancer
Pemetrexed Disodium in the Cerebrospinal Fluid of Patients With Leptomeningeal Metastases
Combination Chemotherapy and Donor Stem Cell Transplant in Treating Patients With Aplastic Anemia or Hematologic Cancer
Study of Pulmonary Hypertension in Patients With Chronic Myeloproliferative Disorders at Sohag University Hospital
Bone Marrow Transplant in Treating Patients With Hematologic Cancers
Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer
Dalteparin to Prevent Complications in Cancer Patients Receiving Chemotherapy Through a Catheter
Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial
Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Myelofibrosis/Myeloproliferative Disorder
Ultraviolet-B Light Therapy and Allogeneic Stem Cell Transplantation in Treating Patients With Hematologic Malignancies
Combination Chemotherapy Followed By Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Severe Aplastic Anemia
Treatment for Chronic Pain in Patients With Advanced Cancer